ABSTRACT Background: Portions of the gastrointestinal (GI) tract may be severely involved in patients with inherited epidermolysis bullosa (EB). Evidence-based data are lacking as to the frequency and time of onset of these complications. Patients and Methods: Cross-sectional and longitudinal data were analyzed on 3,280 and 450 patients with EB, respectively, who were followed from 1986-2002 as part of the National EB Registry, an epidemiological study that attempted to identify, enroll, and collect data on every EB patient residing within the continental United States. Frequencies of abnormalities arising within the esophagus, stomach, small and large intestines, rectum, and anus were determined for each major EB subtype. Cumulative risks were similarly calculated for esophageal stenoses or strictures, and for severe growth retardation. Results: Esophageal strictures and growth retardation were commonly seen among the more severe EB subtypes, most notably Hallopeau-Siemens recessive dystrophic EB, and occurred as early as within the first year of life. EB subtypespecific differences were also observed in the frequency of occurrence of other GI complications. Discussion: A variety of GI complications arise in patients with inherited EB, varying across the major EB subtypes in their relative severity, frequency, and time of onset. Conclusions: Data generated by the National EB Registry should provide a sound basis whereby evidence-based strategies can be implemented for more effective surveillance and treatment of specific GI complications. JPGN 46:147-158, 2008.
Inherited epidermolysis bullosa (EB) encompasses 4 major groups of skin diseases: epidermolysis bullosa simplex, junctional epidermolysis bullosa, dominant dystrophic epidermolysis bullosa, and recessive dystrophic epidermolysis bullosa. Each is characterized by marked mechanical fragility of epithelial tissues and the formation of skin blisters, erosions, and poorly healing ulcers (1) (2) (3) (4) . More than 20 clinically distinct phenotypes (5) and hundreds of genotypes have now been described, including mutations in at least 10 structural genes (6) (7) (8) .
One of the most common sites of extracutaneous injury in inherited EB is the gastrointestinal tract. Painful blisters and erosions may develop within the oral cavity, esophagus, small and large intestines, rectum, and anus. When lumenal blistering is severe and chronic, scarring may lead to the development of strictures. Esophageal strictures are associated with dysphagia or phagodynia, which may impair adequate oral intake. Painful oral erosions also may reduce a patient's desire to eat. When widespread and persistent, intestinal erosions lead to chronic protein and blood loss, thus contributing to the development of multifactorial anemia, hypoalbuminemia, hypoproteinemia, malabsorption, and growth retardation. These combined biochemical abnormalities undoubtedly contribute to impaired wound healing, and also may play a role in a nutritional blunting of the immune system in severely affected patients. Rectal strictures may result in chronic constipation and even megacolon. Painful defecation resulting from anal erosions and fissures may further exacerbate chronic constipation and reduce a patient's willingness to eat.
There are no epidemiological data on the frequency of gastrointestinal complications in inherited EB or on a patient's lifetime risk of developing esophageal strictures. Such data would be invaluable to the clinician because they would assist in predicting which patients are at highest risk for these outcomes, the intensity of surveillance needed, and the timing of medical and surgical interventions.
In 1986 the National Institutes of Health (NIH) established the National Epidermolysis Bullosa Registry (NEBR) (9) , an epidemiological project having both cross-sectional and longitudinal components. One of its major goals was to determine the risk of selected extracutaneous outcomes in inherited EB, including those of the gastrointestinal tract. During its 16 years of continuous funding, 3280 patients were enrolled and evaluated throughout the continental United States at 4 regionally situated clinical centers. The demographics of this study population have been shown to closely mirror that of the entire American population, allowing generalization across the United States (10) . The distribution of patients by major EB type and subtype also has been shown to closely mimic that seen in smaller cohorts of patients with EB elsewhere in the world, suggesting that these data are applicable to patients with EB everywhere.
After rigorous analysis of the registry database, we report on the frequency of gastrointestinal complications and the cumulative risk for developing esophageal strictures in each of the major types and subtypes of inherited EB. We also summarize the frequency with which related surgical interventions have been carried out in this large and well-characterized patient cohort.
MATERIALS AND METHODS
Data were obtained from 3280 consecutively enrolled patients with EB who were seen on behalf of NEBR from September 1986 through April 2002, when formal federal funding for this NIH-supported project ended. During these 16 years of continuous NIH funding, data were collected by co-investigators at several institutions (see Acknowledgments). The distribution of patients by site of enrollment was 55%, 19%, 19%, and 7% at the 4 regional centers. The authors of this publication are members of the research team at the project's Data Coordinating Center, which was responsible for data validation and the performance and interpretation of biostatistical analyses. In addition, this center enrolled the majority of the project's patients.
Written informed consent was obtained from each adult patient, following guidelines of the institutional review boards at each of the participating institutions. When children were involved, written consent and assent were obtained from parents and affected children. A comprehensive data instrument containing nearly 1000 possible data entries was used. The instrument was comprised of a detailed questionnaire (including patient demographics, past and present medical history, family history, and socioeconomic data), physical examination, and results of diagnostic laboratory studies. During the last 5 years of funding, Whenever possible, each enrollee was seen and physically examined at least once by one of the project's principal investigators. The diagnosis of EB was confirmed in every case by immunofluorescence antigenic mapping, EB-specific monoclonal antibody studies, and transmission electron microscopy (5). Each patient was assigned to an EB subtype according to a widely used classification scheme reported in 1991 (11) and updated in 2000 by an international panel of EB experts (5) .
We separated the patients into several mutually exclusive EB subtypes, following the detailed criteria of the most recent classification scheme (5): epidermolysis bullosa simplex, Weber-Cockayne (EBS-WC); epidermolysis bullosa simplex, herpetiformis, Dowling-Meara (EBS-DM); epidermolysis bullosa simplex, Koebner (EBS-K); epidermolysis bullosa simplex, all others (EBS-O); junctional epidermolysis bullosa, Herlitz (JEB-H); junctional epidermolysis bullosa, non-Herlitz (JEB-nH); dominant dystrophic epidermolysis bullosa (DDEB); generalized recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens (RDEB-HS); recessive dystrophic epidermolysis bullosa, inversa (RDEB-I); and generalized recessive dystrophic epidermolysis bullosa, non-Hallopeau-Siemens (RDEB-nHS) ( Table 1 ). There were sufficient data on 2748 patients (83.8%) enrolled in NEBR to permit subclassification into these 10 major EB subtypes. These assigned patients served as the final cohort from which gastrointestinal data were extracted. Because occasional patients were unable to provide complete information on certain questions, the N values listed in the accompanying tables represent the average number of respondents for each finding.
Approximately 450 well-characterized patients were randomly selected from the overall study population for longitudinal follow-up on a biennial basis during the last 10 years of this project (12) . Random selection was performed within each major EB subtype. Given differences in overall numbers of enrollees in the different subtypes, larger percentages were randomly sampled in the rarer subtypes, using an algorithm described previously (12) , so as to maximally sample those EB subtypes most at risk for significant extracutaneous disease, severe cutaneous disease activity, and clinically relevant sequelae. In doing so, consideration was given to biostatistical power. For example, in the case of RDEB-I, all patients were followed prospectively, given how few patients were available for study. In contrast, only a small percentage of patients with EBS-WC were randomly chosen for longitudinal follow-up.
Data collection was entered into specially designed templates originally based on Clinfo and later on EpiInfo software (Centers for Disease Control and Prevention, Atlanta, GA). SAS datasets (SAS Institute, Cary, NC) were subsequently generated to facilitate the performance of more sophisticated biostatistical analyses. All biostatistical analyses were conducted under the direct supervision of the project's designated biostatistician (C.S.), who did not know the identities of patients.
Results are presented as frequencies of occurrence for each major gastrointestinal complication, using prevalence data. Cumulative probabilities for development of esophageal strictures and growth retardation were calculated for each major EB Table 2 summarizes NEBR experience with esophageal complications. These represent frequencies of occurrence, and as such, do not take into account patient age or time of onset. In general, the frequency of esophageal complaints correlated with the relative severity of underlying EB, measured both in cutaneous surface area affected with blisters and the ultrastructural depth of blister formation (ie, EBS < JEB < DEB). The most common symptom was dysphagia, ranging from 1.37% in patients with localized EBS (EBS-WC) to 100% in patients with RDEB-I. As expected, fewer patients reported esophageal stenosis or strictures (range 0% in EBS-DM to 86.67% in RDEB-I). Gastroesophageal reflux disease was a less common complaint, with the highest frequency (13.95%) in JEB-H patients. Only rare patients reported esophageal spasms or Mallory Weiss tears, and only 1 patient, with RDEB-I, experienced an esophageal perforation as a result of therapeutic dilatation.
RESULTS
To determine the influence of age on the risk of esophageal stenoses or strictures, we performed life-table analyses, stratified by major EB subtype ( Fig. 1 and Table 3 ). The most striking cumulative risk of this complication was seen in RDEB-HS, with 6.73%, 35.19%, 57.40%, 79.14%, and 94.72% developing esophageal stenosis or strictures by ages 1, 5, 10, 20, and 45, respectively. A similar curve, but with a less steep slope, was observed in RDEB-nHS, with nearly 70% experiencing esophageal stenosis or strictures by age 50. In contrast, by age 20 about one third of all JEB-H patients had developed stenosis or strictures, and by age 30 nearly 90% of all RDEB-I patients were affected. Table 4 summarizes the frequency of gastric complications in EB. In general, only rare patients experienced gastritis or peptic ulcer disease. Similarly, the only EB subtype at risk for pyloric stenosis or atresia was JEB-nH, and of those patients, each represented the rare condition now referred to as the JEB-pyloric atresia syndrome. Characteristic of the latter entity, pyloric atresia was observed at birth in these patients. Table 5 summarizes the frequency of lower gastrointestinal tract complications inherited in patients with EB. The most common complaint was constipation, present in about 25%, 20%, 20%, 20%, 50%, 75%, and 75% of patients with EBS-DM (the most severe variant of EBS), JEB-H, JEB-nH, DDEB, RDEB-nHS, RDEB-HS, and RDEB-I, respectively. Diarrhea was a rare or infrequent complaint in all of the major EB subtypes, as were rectal tears, rectal prolapse, rectal strictures, perianal fistulas, encopresis, megacolon, inflammatory bowel disease, 
150
FINE ET AL.
irritable bowel disease, diverticulosis, hemorrhoids, or intussusception. Painful anal fissures, however, were seen in some patients with RDEB (range 3.55% in RDEB-HS to 11.76% in RDEB-I), as were anal strictures (in up to about 25% of all patients with either RDEB-HS or RDEB-I). Table 6 summarizes the Registry's experience with esophageal dilatation. This included dilatations using a variety of instruments and techniques, including manometrically controlled balloon catheters and mercury-filled bougies. There was no difference in the success of dilatation by any individual technique or device. Dilatations were performed rarely in patients with EBS, JEB, and DDEB. In contrast, 36.03%, 28.29%, and 70.59% of all patients with RDEB-HS, RDEB-nHS, and RDEB-I, respectively, underwent at least 1 dilatation. Despite the relatively small number of patients with JEB requiring dilatation, the mean number of dilations per patient in our JEB-H population was 7.5. Among our RDEB patients, the mean number of dilatations ranged from 4.75 (RDEB-nHS) to 7.83 (RDEB-I), with rare patients requiring as many as 50 procedures. The time between successive dilations in a single patient was variable, ranging from months to years. As noted above, only 1 patient experienced a minor esophageal perforation as a result of dilation, and in that patient surgical intervention was not required.
Severely affected EB children often fail to gain weight. Contributing causes include poor intake of nutrients as a result of severe oral and esophageal disease activity; excessive energy expenditure, analogous to that seen in patients with severe burns; and secondary malabsorption or loss of nutrients, due to chronic mucosal erosions of the small intestine. The end results of these combined factors are profound growth retardation and failure to thrive. As noted in Fig. 2 , the cumulative risk of growth retardation was highest in JEB-H and RDEB-HS, with risks of 52.59% by age 2 in JEB-H and 79.41% by age 20 in RDEB-HS.
Gastrostomy was rarely performed in the first 10 years of the project's existence. Recently, however, feeding gastrostomy has become a first-line intervention in the nutritional management of patients with EB (Table 7) . Gastrostomies were placed most commonly in RDEB-HS (44.20%) and JEB-H (40.00%) patients, and in about 20% of JEB-nH and RDEB-nHS patients. We are aware of only rare patients who experienced problems with perigastrostomy leakage, although this was not systematically documented, and these problems usually resolved after temporary removal of the appliance to allow the stoma to contract in size. Similarly, physical discomfort secondary to the gastrostomy appliance was an infrequent complaint and was minimized by nonadhesive padding of the skin around the gastrostomy device. 
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Sixteen patients, all with RDEB, whose esophageal strictures prevented oral intake and were unresponsive to dilation, underwent esophageal replacement by colonic transposition. As summarized in Table 8 , the frequency of this procedure ranged from 3.52% of RDEB-nHS patients to 5.88% of all RDEB-I patients. There were no reports of intraoperative or postsurgical complications.
Total parenteral nutrition (TPN) was used in all subtypes of EB, in an effort to supplement oral nutritional intake and offset secondary malabsorption and energy loss from small-intestinal disease activity. As noted in Table 9 , TPN was most commonly used in RDEB-HS, in both major subtypes of JEB, and to a lesser extent in EBS-DM and the other 2 RDEB subtypes.
DISCUSSION
Dysphagia and esophageal strictures are well-known complications of inherited EB, especially dystrophic disease. Intraesophageal bullae have been observed and documented radiographically (13) . There appears to be no sex predilection for this complication (14) . The largest well-characterized series to date involved 246 patients with EB seen between 1980 and 1990 at the St. John's Hospital for Skin Diseases in London (15) . In this group, dysphagia was observed in 2%, 15%, 27%, and 54% of all patients with EBS, JEB, DDEB, and RDEB, respectively. Overall, the mean onset of symptoms was 17 years (range 4-47 years), although no data were provided by the authors as to possible differences in onset of dysphagia in different EB subtypes. In 62 patients on whom examinations were possible, strictures and webs were detected in 32 (51.6%) and 6 (9.7%), respectively. In addition, 1 patient had a pharyngeal pouch and another reported having coughed up an esophageal cast. The latter phenomenon also has been reported by others (16) . Another patient developed a double-barreled esophageal deformity (false lumen) after a stricture ulcerated and dissected into the muscularis mucosa and other longitudinal muscle layers of the esophagus, finally fistulizing into the mediastinum (17) .
Other smaller series, in general, have reported similar frequencies of dysphagia within each of the major EB subtypes (14,18), especially RDEB, in which about three fourths of all patients were symptomatic. In most of these series, the frequency of dysphagia was higher than that of esophageal strictures, which is plausible because presumably strictures arise only after prolonged injury to the esophagus.
Previous studies have reported the mean age of onset of dysphagia in EB to be between 11.25 and 17 years (14, 15, 19, 20) . However, dysphagia also has been reported in early childhood, with 1 patient, reported by Mauro et al (20) , developing symptoms by age 1 year. In a more recent series of 22 patients, published in 2002, the mean 
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age of onset of dysphagia was 48 months, with the earliest occurring by 10 months of age (21) . EB-associated strictures may arise anywhere in the esophagus. In most series (18) (19) (20) 22) , at least half (range 50%-78%) occurred in the upper third of the esophagus. Of the remainder, the middle third of the esophagus was affected more often than the distal third. Esophageal webs also occur in patients with EB (14, 16, 23) . Occasionally, they rupture spontaneously, resulting in an immediate resolution of symptoms. Of note, when webs occur in patients with EB, they do not appear to be associated with any other concurrent syndrome (16) . Multiple esophageal strictures or webs may develop in patients with EB. In 3 small series, multiple strictures were noted in 11.1% to 31.2% of patients (14, 18, 20) . In another series of 25 RDEB patients, 28% had 2 strictures and 12% had 3 (22) .
Stricture length was measured in 16 RDEB patients by barium esophagram in a study by Mauro et al (20) . Stricture length ranged from 2 mm to 15 cm. Longer strictures were described as having tapered margins. In another series of 25 RDEB patients, stricture length ranged from 5 mm to 8 cm (14) .
In the present study, we performed life-table analyses on 3280 patients with EB, in an effort to more precisely define the risk of esophageal strictures in each EB subtype. Confirming previous reports, we found that patients with RDEB-HS had the highest cumulative risk, with more than half of these patients affected by age 10.
Other EB subtypes were also at considerable risk. Our data also document that this complication may arise early in childhood, with a much higher frequency than previously appreciated. Among NEBR participants, nearly 7% of RDEB-HS children developed this complication by age 1 year. Given the method by which patients were recruited and then prospectively sampled (12) , it is unlikely that this figure represents an overestimation of risk due to recruitment, reporting, or classification biases. Our findings, therefore, suggest the need for careful monitoring for symptoms and signs of esophageal stricture even in early childhood, so as to permit appropriate corrective intervention. It is important to note that based on this large population and the length of followup, there does not appear to be an increased risk of esophageal carcinoma in patients with EB as a result of chronic strictures. We suggest that the goal of surveillance in these patients is to prevent further stenoses from developing, which otherwise would impair nutritional intake.
Other esophageal problems reported in patients with EB include prestenotic dilatation, hiatal hernia, gastroesophageal reflux, esophagitis, uncoordinated peristalsis, decreased peristalsis, intramural pseudodiverticula, esophageal atony, and shortening of the esophagus (in conjunction with a traction-type hiatal hernia) (14) .
There is more than 30 years' published experience with esophageal dilatation in inherited EB (15, 16, 21, 22, (24) (25) (26) . A variety of techniques and instruments have been used successfully, including balloon catheters and mercury-filled bougies, guided fluoroscopically or endoscopically. In most recent series, physicians and surgeons have used balloons rather than bougies, because the former applies only radial distention forces to the esophagus in contrast to bougies, which also apply longitudinal shearing forces to the esophageal wall, thereby potentially increasing the risk of esophageal erosion or perforation (22, 27) . Although usually performed in an antegrade direction, dilation occasionally has been performed retrograde via gastrostomy when the proximal esophageal lumen is obscured (24) or in patients with severe microstomia and oral contractures (22) .
In a large series from Stanford University, 109 dilatations were performed with endoscopic guidance in 22 RDEB children over 9 years (21) . The average time between the onset of symptoms and dilatation was 33 months (range 1 month-10 years). A single dilation was performed in only 6 of the 22 children. The mean interval between dilations was 11 months (range 1 month->3 years). In general, dilation was well tolerated, and patients were able to swallow solid food within 6 hours. Only 2 complications occurred (intramural esophageal tear and aspiration of contrast media), and both resolved with conservative management. In the London series, dilation frequency for each major EB subtype was reported (15); 54% of patients with RDEB and 27% of patients with DDEB underwent dilations. Dilation was not performed in EBS or JEB.
In a recent publication, Azizkhan et al (22) summarized their experience with 92 balloon dilatations performed with fluoroscopic guidance on 25 RDEB patients between August 1993 and March 2005. Only 24% required a single dilation, consistent with the experience of others. An average of 4 dilatations was performed on each patient, with a range of 1 to 14. The mean interval between dilatations was 1 year (range 1.5 months-4.5 years). Most of these patients experienced immediate relief of dysphagia and were able to resume adequate oral intake within a day. No complications were reported as a result of dilation. Many of these patients were given perioperative and postoperative corticosteroids, and were treated postoperatively with a proton pump inhibitor or histamine H-2 acid reducers to prevent acid gastroesophageal reflux.
In the present study, we have assessed the NEBR experience with other gastrointestinal complications. Despite predictions to the contrary (22), gastroesophageal reflux disease was extremely uncommon in our study population, with the exception of JEB-H patients, in whom 13% reported symptoms. None of our patients was treated routinely with proton pump inhibitors or histamine H-2 acid reducers. Because it is well known that the vast majority of strictures arise within the upper two thirds of esophagus in patients with EB, it seems Another gastrointestinal complication in EB is constipation. Constipation may partially be the result of conscious or reflex refusal to defecate because of painful anal erosions, fissures, or strictures. Among the 246 patients followed in London over a 10-year period, 67%, 13%, 9%, and 3% of all patients with RDEB, DDEB, JEB, and EBS, respectively, reported constipation. In 1 of the larger series, 4 of 25 RDEB children who were evaluated for esophageal complaints had concurrent fecal impaction (14) . In another series, among 7 symptomatic RDEB patients, 6 had fecal impaction documented radiographically (20) .
We found that about 25% of patients with RDEB-HS and RDEB-I had experienced anal strictures. As a correlate, constipation was a common complaint among the NEBR population, seen in about 77% of both RDEB-HS and RDEB-I patients, 50% of RDEB-nHS patients, and about 20% of JEB and DDEB patients. A variety of medical interventions were used for constipation by our patients, but we cannot draw any conclusion about efficacy.
TPN was used in many patients enrolled in NEBR. Although the indication for parenteral nutrition cannot be ascertained for every patient, most received TPN to treat growth retardation. Poor oral intake caused by painful mouth lesions, or poor wound healing thought to be secondary to malnutrition, were 2 common concurrent reasons for starting TPN. Whereas only rare patients with localized EBS and DDEB underwent TPN, about 10% of all EBS-DM and RDEB-I patients, 15% of RDEB-nHS patients, 25% of JEB-nH patients, 30% of RDEB-HS patients, and 33% of all JEB-H patients were treated with intravenous nutrition at some point.
In our study population, feeding gastrostomy placement was primarily used in severely affected patients with RDEB and JEB, and less frequently in other EB subtypes, most notably EBS-DM (8.9%) ( Table 5) . During the earlier years of the Registry, many of our patients had rather bulky gastrostomy tubes. More recently, smaller button appliances have been used. With the introduction of the latter, more patients have received gastrostomies at an earlier age in the hope that early intervention will better treat severe disease activity and intestinal loss and malabsorption of nutrients. Among our patients, the highest frequencies of gastrostomy placements were in JEB-H (40.0%) and RDEB-HS (44.2%) patients, consistent with the high frequency of 
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esophageal strictures, malnutrition, and secondary growth retardation in these 2 severe generalized EB subtypes. Lesser frequencies were noted in JEB-nH, RDEB-nHS, and RDEB-I patients (range 12.8-22.9%). Although the mean number of gastrostomy procedures was 1 per patient in each major EB subtype, as many as 10 placements occurred in rare patients. Leakage around the gastrostomy sites was reported by a few patients; however, it was not formally tabulated. It led to superficial erosions of the skin. After temporary removal of these tubes and topical care of the wounds, replacement with new gastrostomy appliances was later possible. Colonic interposition or transposition has been performed in rare patients with EB with severe esophageal strictures that could not be managed with dilatation (24) . Among the NEBR population, 16 patients underwent colonic transposition, corresponding to 4.4%, 3.5%, and 5.9% of all patients with RDEB-HS, RDEB-nHS, and RDEB-I, respectively ( Table 6 ). The mean and median ages at the time of surgery were 17.2 years and 15.5 years, respectively. These procedures were well tolerated in all patients, permitting resumption of oral feedings.
The findings of NEBR, which have been stratified by major EB subtype, should provide valuable practical information to clinicians caring for patients with inherited EB as they monitor for and treat extracutaneous complications. It is clear that that some types of gastrointestinal complications are prevalent in certain EB subtypes, and that some complications, most notably esophageal strictures and growth retardation, may begin in early childhood. Of all EB subtypes, the 1 having the highest overall risk for major gastrointestinal complications is RDEB-HS, although all RDEB subtypes, and to a lesser extent JEB subtypes, deserve particularly close surveillance. Similarly, growth retardation is a major concern in JEB-H and RDEB-HS. Many of these complications may be improved or even corrected if appropriate intervention is used early by skilled and experienced specialists (pediatric and adult gastroenterologists, pediatric surgeons, and nutritionists). Our data demonstrate that the timing and focus of surveillance for gastrointestinal tract complications should be planned according to EB subtype. Use of our findings in a multidisciplinary team approach should improve the care and quality of life of even the most severely affected patients with EB.
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